MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Net Block History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Block | ₹18,620 Cr | ₹19,004 Cr | ₹4,540 Cr | ₹4,245 Cr | ₹3,583 Cr |
What is the latest Net Block ratio of MANKIND PHARMA ?
| Year | Net Block |
|---|---|
| Mar2026 | ₹18,620 Cr |
| Mar2025 | ₹19,004 Cr |
| Mar2024 | ₹4,540 Cr |
| Mar2023 | ₹4,245 Cr |
| Mar2022 | ₹3,583 Cr |
How is Net Block of MANKIND PHARMA Trending?
| Years | Net Block | % Change | |
|---|---|---|---|
| Mar2026 | ₹18,620 Cr | -2.02 | |
| Mar2025 | ₹19,004 Cr | 318.61 | |
| Mar2024 | ₹4,540 Cr | 6.94 | |
| Mar2023 | ₹4,245 Cr | 18.49 | |
| Mar2022 | ₹3,583 Cr | - | |
Compare Net Block of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹104,365.1 Cr | 2.1% | 7.1% | -0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.1% |
7.1% |
-0.6% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses